Attached files

file filename
EX-31.1 - CERTIFICATION - Innovation Pharmaceuticals Inc.ipix_ex311.htm
EX-23.1 - CONSENT - Innovation Pharmaceuticals Inc.ipix_ex231.htm
10-K - FORM 10-K - Innovation Pharmaceuticals Inc.ipix_10k.htm

EXHIBIT 32.1

 

 

 

Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)

 

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officer of Innovation Pharmaceuticals Inc., a Nevada corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:

 

 

·

The Annual Report on Form 10-K for the fiscal year ended June 30, 2020 of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

 

 

 

·

the information contained in the Annual Report on Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: September 14, 2020

By:

/s/ Leo Ehrlich

 

 

 

Leo Ehrlich,

 

 

 

Chief Executive Officer, Chief Financial Officer,

 

 

 

Principal Accounting Officer, and Secretary

&n